Prognostic Importance of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Multiple Myeloma Patients

Read full text Summarise with VIRAT
Authors: Alperen Kızıklı, Vahap Okan
Cited by: 0
References: 15

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objectives: To evaluate the prognostic significance of baseline neutrophil-to-lymphocyte ratio (NLR) and platelet-tolymphocyte ratio (PLR) in newly diagnosed multiple myeloma (MM).Methods: We retrospectively analyzed 327 MM patients (2012-2018) from a single tertiary center.Baseline clinical, hematologic, and biochemical data were collected.NLR and PLR were calculated.OS was estimated via Kaplan-Meier and Cox regression.ROC analysis determined an NLR cutoff.Results: Median OS was 46.1 months; 1-, 2-, and 5-year OS rates were 77.4%, 64.5%, and 44.0%, respectively.Each oneunit increase in NLR raised the risk of death by 9.3% (HR 1.093; p=0.015).NLR correlated with poorer OS in ISS stage II, hemoglobin

Fields of Study & Subjects

Inflammatory Biomarkers in Disease Prognosis Multiple Myeloma Research and Treatments Lung Cancer Research Studies

Publication details

Journal / source
Eurasian Journal of Medical Advances
Pages
17–24
Publication date
1 January 2026
Language
EN